These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31372331)
1. Prediction and evaluation of neoadjuvant chemotherapy using the dual mechanisms of Wu C; Wang Q; Li Y J Bone Oncol; 2019 Aug; 17():100250. PubMed ID: 31372331 [TBL] [Abstract][Full Text] [Related]
2. Is (99m)Tc-MIBI scintigraphy a predictor of response to pre-operative neoadjuvant chemotherapy in Osteosarcoma? Gharehdaghi M; Dabbagh Kakhki VR; Khooei A; Novferesti G; Hootkani A; Farzadnia M; Sadeghi R Asia Ocean J Nucl Med Biol; 2013; 1(2):22-7. PubMed ID: 27408846 [TBL] [Abstract][Full Text] [Related]
3. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma]. Huang ZK; Lou C; Shi GH Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516 [TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression. Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182 [TBL] [Abstract][Full Text] [Related]
6. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography. Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769 [TBL] [Abstract][Full Text] [Related]
7. Application of the alteration uptake ratio of Huang Z; Lou C Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817 [TBL] [Abstract][Full Text] [Related]
8. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens. Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016 [TBL] [Abstract][Full Text] [Related]
9. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy. Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785 [TBL] [Abstract][Full Text] [Related]
10. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293 [TBL] [Abstract][Full Text] [Related]
11. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities. Moustafa H; Riad R; Omar W; Zaher A; Ebied E Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955 [TBL] [Abstract][Full Text] [Related]
12. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma. Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696 [TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients. Sergieva SB; Timcheva KV; Hadjiolov ND J BUON; 2006; 11(1):61-8. PubMed ID: 17318954 [TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer. Duan XY; Wang JS; Liu M; Guo YM Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT. Du C; Ying H; Zhou J; Jiang J; Liu C; Chen J; Wang X; Hu C Med Oncol; 2014 Feb; 31(2):833. PubMed ID: 24402323 [TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Akgun A; Cok G; Karapolat I; Goksel T; Burak Z Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570 [TBL] [Abstract][Full Text] [Related]
17. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy. Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675 [TBL] [Abstract][Full Text] [Related]
18. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer. Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer. Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482 [TBL] [Abstract][Full Text] [Related]